Log in to access your PharmaMiles
and download the data
| Last Updated on PharmaCompass | Virtual Booth | Country | Holder | DMF No. | Subject | Submission Date | Status | Type | GDUFA DMF Review | GDUFA Review Date | GDUFA Payment Date |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 28/03/2025 | Cleave Therapeutics |
U.S.A |
CASI PHARMACEUTICALS INC | 34034 | CB 5339 DRUG SUBSTANCE | 2019-09-06 | Active | II | N/A | ||
| 28/03/2025 | Cleave Therapeutics |
U.S.A |
CASI PHARMACEUTICALS INC | 34023 | CB-5339 DRUG PRODUCT | 2019-09-06 | Active | II | N/A |
